Ultherapy PRIME acquires FDA approval
Pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for Ultherapy PRIME for skin laxity on the knees. The company shares that this approval on the
Pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for Ultherapy PRIME for skin laxity on the knees. The company shares that this approval on the
Aesthetic pharmaceutical company Merz Aesthetics has announced the UK launch of the Ultherapy PRIME device. According to the company, Ultherapy PRIME builds on the success of the original Ultherapy, using